Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Russell

Showing results (871-880 of 920) with videos related to

Pageof 92
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 16, 2025
Virus-free CRISPR knockin of a chimeric antigen receptor into KLRC1 generates potent GD2-specific natural killer cellsKeerthana Shankar, Isabelle Zingler-Hoslet, Diana M Tabima, et al.
Ecohealth|June 24, 2017
Sylvatic Plague Vaccine Partially Protects Prairie Dogs (Cynomys spp.) in Field TrialsTonie E Rocke, Daniel W Tripp, Robin E Russell, et al.
Medrxiv : the Preprint Server for Health Sciences|April 8, 2024
Data-driven consideration of genetic disorders for global genomic newborn screening programsThomas Minten, Sarah Bick, Sophia Adelson, et al.
Plos One|September 13, 2012
A novel HLA-B18 restricted CD8+ T cell epitope is efficiently cross-presented by dendritic cells from soluble tumor antigenRona Y Zhao, Nicole A Mifsud, Kun Xiao, et al.
Telemedicine Reports|October 27, 2025
Feasibility of Intensive Multidisciplinary Telerehabilitation Combined with Health Coaching for Underserved Stroke Survivors: A Pilot StudyEmily A Stevens, Robert Suchting, Jane A Anderson, et al.
Molecular Psychiatry|July 22, 2009
The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophreniaE K Green, D Grozeva, I Jones, et al.
Diabetes|November 14, 2025
Baseline Insulin Secretion Determines Response to Abatacept in Stage 1 Type 1 DiabetesAlfonso Galderisi, Alice L J Carr, Peter Taylor, et al.
Diabetes Care|April 15, 2024
Early Metabolic Endpoints Identify Persistent Treatment Efficacy in Recent-Onset Type 1 Diabetes Immunotherapy TrialsLaura M Jacobsen, David Cuthbertson, Brian N Bundy, et al.
Lancet (London, England)|July 2, 2011
Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trialTihamer Orban, Brian Bundy, Dorothy J Becker, et al.
Diabetes Care|December 4, 2013
Costimulation modulation with abatacept in patients with recent-onset type 1 diabetes: follow-up 1 year after cessation of treatmentTihamer Orban, Brian Bundy, Dorothy J Becker, et al.
Pageof 92

Showing results (871-880 of 920) with videos related to

Sort By:
Pageof 92
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 16, 2025
Virus-free CRISPR knockin of a chimeric antigen receptor into KLRC1 generates potent GD2-specific natural killer cellsKeerthana Shankar, Isabelle Zingler-Hoslet, Diana M Tabima, et al.
Ecohealth|June 24, 2017
Sylvatic Plague Vaccine Partially Protects Prairie Dogs (Cynomys spp.) in Field TrialsTonie E Rocke, Daniel W Tripp, Robin E Russell, et al.
Medrxiv : the Preprint Server for Health Sciences|April 8, 2024
Data-driven consideration of genetic disorders for global genomic newborn screening programsThomas Minten, Sarah Bick, Sophia Adelson, et al.
Plos One|September 13, 2012
A novel HLA-B18 restricted CD8+ T cell epitope is efficiently cross-presented by dendritic cells from soluble tumor antigenRona Y Zhao, Nicole A Mifsud, Kun Xiao, et al.
Telemedicine Reports|October 27, 2025
Feasibility of Intensive Multidisciplinary Telerehabilitation Combined with Health Coaching for Underserved Stroke Survivors: A Pilot StudyEmily A Stevens, Robert Suchting, Jane A Anderson, et al.
Molecular Psychiatry|July 22, 2009
The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophreniaE K Green, D Grozeva, I Jones, et al.
Diabetes|November 14, 2025
Baseline Insulin Secretion Determines Response to Abatacept in Stage 1 Type 1 DiabetesAlfonso Galderisi, Alice L J Carr, Peter Taylor, et al.
Diabetes Care|April 15, 2024
Early Metabolic Endpoints Identify Persistent Treatment Efficacy in Recent-Onset Type 1 Diabetes Immunotherapy TrialsLaura M Jacobsen, David Cuthbertson, Brian N Bundy, et al.
Lancet (London, England)|July 2, 2011
Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trialTihamer Orban, Brian Bundy, Dorothy J Becker, et al.
Diabetes Care|December 4, 2013
Costimulation modulation with abatacept in patients with recent-onset type 1 diabetes: follow-up 1 year after cessation of treatmentTihamer Orban, Brian Bundy, Dorothy J Becker, et al.
Pageof 92